Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
In this study, we investigated the role of PVAT in the progression of abdominal aortic aneurysm (AAA) and hypothesized that deletion of angiotensin II (Ang II) type 1a (AT1a) receptor in PVAT could attenuate AAA in apolipoprotein E-deficient (ApoE-/-) mice. ApoE-/-AT1a-/- PVAT transplantation significantly attenuated AAA in ApoE-/- recipient mice compared to ApoE-/- PVAT transplanted ApoE-/- recipient mice. On the other hand, ApoE-/- PVAT transplantation significantly exaggerated AAA in ApoE-/-AT1a-/- recipient mice compared to ApoE-/-AT1a-/- transplanted ApoE-/-AT1a-/- recipient mice. Accumulation of macrophage and expression of inflammatory cytokines was attenuated in ApoE-/-AT1a-/- donor PVAT compared to ApoE-/- donor PVAT. Moreover, expression of osteopontin and activity of matrix metalloprotease (MMP)-2, 9 were largely attenuated in ApoE-/-AT1a-/- donor PVAT compared to ApoE-/- donor PVAT.
|